Decompression Intervention of Variceal Rebleeding Trial (DIVERT)
NCT ID: NCT00006161
Last Updated: 2010-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
140 participants
INTERVENTIONAL
1996-12-31
2003-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is recognized nationally and internationally as the study that will answer the question as to which of these is the best treatment for decompression of varices in patients who have failed endoscopic and pharmacologic therapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Study the Hemodynamic Response of Early Addition of Carvedilol to Terlipressin in Acute Variceal Bleed in Child's B and C Cirrhosis
NCT05699824
Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis
NCT06122792
Early TIPS in Patients With Liver Cirrhosis and Ascites
NCT06576934
Band Ligation Versus Transjugular Intrahepatic Portosystemic Stent Shunt (TIPS) in Cirrhotics With Recurrent Variceal Bleeding Non Responding to Medical Therapy
NCT00570973
TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
NCT02485184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Distal Splenorenal Shunt
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Child's Class A or B cirrhosis of any etiology
* Patients who have failed endoscopic therapy (sclerotherapy or banding) of varices; or patients who are not candidates for endoscopic therapy
Exclusion Criteria
* Portal vein thrombosis
* Polycystic liver disease
* Intractable ascites
* Prior organ transplant
* Any medical intractable disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J. Michael Henderson, M.D.
Role: PRINCIPAL_INVESTIGATOR
The Cleveland Clinic
Thomas D. Boyer, M.D.
Role: PRINCIPAL_INVESTIGATOR
Emory University
Lennox Jeffers, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Enrique Molina, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Layton F. Rikkers, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Kareem Abu-Elmagd, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh Medical Center
Amrik Shah, Sc.D.
Role: PRINCIPAL_INVESTIGATOR
Cleveland Clinic Foundation - Data Coordinating Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami School of Medicine
Miami, Florida, United States
Emory University
Atlanta, Georgia, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
University of Wisconsin
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Boyer TD, Henderson JM, Heerey AM, Arrigain S, Konig V, Connor J, Abu-Elmagd K, Galloway J, Rikkers LF, Jeffers L; DIVERT Study Group. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol. 2008 Mar;48(3):407-14. doi: 10.1016/j.jhep.2007.08.014. Epub 2007 Oct 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DK50680-02
Identifier Type: -
Identifier Source: secondary_id
DIVERT (completed)
Identifier Type: -
Identifier Source: org_study_id
NCT00004469
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.